Quadiri A, Prakash S, Zayou L, Dhanushkodi N, Chilukuri A, Ryan G
Vaccines (Basel). 2025; 13(1).
PMID: 39852826
PMC: 11769137.
DOI: 10.3390/vaccines13010047.
Katzmarzyk M, Naughton R, Sitaras I, Jacobsen H, Higdon M, Knoll M
Vaccines (Basel). 2024; 12(11).
PMID: 39591141
PMC: 11598362.
DOI: 10.3390/vaccines12111238.
Erkihun M, Ayele B, Asmare Z, Endalamaw K
Health Sci Rep. 2024; 7(11):e70166.
PMID: 39502131
PMC: 11534727.
DOI: 10.1002/hsr2.70166.
Im K, Kim N, Lee J, Oh U, Lee H, Lee D
Int J Mol Sci. 2024; 25(19).
PMID: 39408840
PMC: 11477143.
DOI: 10.3390/ijms251910512.
Pham L, Underwood A, Binderup A, Fahnoe U, Fernandez-Antunez C, Lopez-Mendez B
Emerg Microbes Infect. 2024; 13(1):2412643.
PMID: 39392057
PMC: 11562025.
DOI: 10.1080/22221751.2024.2412643.
Insight into genomic organization of pathogenic coronaviruses, SARS-CoV-2: Implication for emergence of new variants, laboratory diagnosis and treatment options.
Bedada F, Gorfu G, Teng S, Neita M
Front Mol Med. 2024; 2:917201.
PMID: 39157715
PMC: 11328875.
DOI: 10.3389/fmmed.2022.917201.
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2.
Kumar A, Tripathi P, Kumar P, Shekhar R, Pathak R
Vaccines (Basel). 2024; 12(5).
PMID: 38793710
PMC: 11125746.
DOI: 10.3390/vaccines12050459.
Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques.
Warner B, Chan M, Tailor N, Vendramelli R, Audet J, Meilleur C
Vaccines (Basel). 2024; 12(4).
PMID: 38675786
PMC: 11054841.
DOI: 10.3390/vaccines12040404.
A proposed analytical approach to estimate excess daily mortality rates in Ecuador.
Fernandez-Naranjo R, Vasconez-Gonzalez J, Izquierdo-Condoy J, Landazuri S, Castillo D, Ortiz-Prado E
Front Public Health. 2024; 12:1250343.
PMID: 38525341
PMC: 10957652.
DOI: 10.3389/fpubh.2024.1250343.
Recurring SARS-CoV-2 variants: an update on post-pandemic, co-infections and immune response.
Verma A, Manojkumar A, Dhasmana A, Tripathi M, Jaggi M, Chauhan S
Nanotheranostics. 2024; 8(2):247-269.
PMID: 38444741
PMC: 10911975.
DOI: 10.7150/ntno.91910.
A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster....
Prakash S, Dhanushkodi N, Singer M, Quadiri A, Zayou L, Vahed H
bioRxiv. 2024; .
PMID: 38405942
PMC: 10888826.
DOI: 10.1101/2024.02.14.580225.
COV2Var, a function annotation database of SARS-CoV-2 genetic variation.
Feng Y, Yi J, Yang L, Wang Y, Wen J, Zhao W
Nucleic Acids Res. 2023; 52(D1):D701-D713.
PMID: 37897356
PMC: 10767816.
DOI: 10.1093/nar/gkad958.
Detection of SARS-CoV-2 Δ426 ORF8 Deletion Mutant Cluster in NGS Screening.
Cecchetto R, Tonon E, Medaina N, Turri G, Diani E, Piccaluga P
Microorganisms. 2023; 11(10).
PMID: 37894036
PMC: 10609088.
DOI: 10.3390/microorganisms11102378.
Overview of immunological & virological factors driving the evolution & global spread of SARS-CoV-2 variants.
Ramasamy R
Indian J Med Res. 2023; 158(3):257-268.
PMID: 37815068
PMC: 10720969.
DOI: 10.4103/ijmr.ijmr_2591_22.
Structure, dynamics and free energy studies on the effect of point mutations on SARS-CoV-2 spike protein binding with ACE2 receptor.
Rucker G, Qin H, Zhang L
PLoS One. 2023; 18(10):e0289432.
PMID: 37796794
PMC: 10553274.
DOI: 10.1371/journal.pone.0289432.
Comparative Study of the Mutations Observed in the SARS-CoV-2 RBD Variants of Concern and Their Impact on the Interaction with the ACE2 Protein.
Ghoula M, Kongmeneck A, Eid R, Camproux A, Moroy G
J Phys Chem B. 2023; 127(40):8586-8602.
PMID: 37775095
PMC: 10578311.
DOI: 10.1021/acs.jpcb.3c01467.
Vaccination is the most effective and best way to avoid the disease of COVID-19.
Lotfi H, Mazar M, Ei N, Fahim M, Yazdi N
Immun Inflamm Dis. 2023; 11(8):e946.
PMID: 37647441
PMC: 10408370.
DOI: 10.1002/iid3.946.
Characterization of a mouse-adapted strain of bat severe acute respiratory syndrome-related coronavirus.
Lin H, Liu M, Jiang R, Gong Q, Su J, Guo Z
J Virol. 2023; 97(9):e0079023.
PMID: 37607058
PMC: 10537601.
DOI: 10.1128/jvi.00790-23.
An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant.
Yuan M, Zhu Y, Liu G, Wang Y, Wang G, Zhang G
One Health Adv. 2023; 1(1):12.
PMID: 37521533
PMC: 10173222.
DOI: 10.1186/s44280-023-00012-0.
The high mutation rate at the D614G hotspot-furin cleavage site region increases the priming efficiency of the Spike protein by furin protease: analysis of Indonesian SARS-CoV-2 G614 variants obtained during the early COVID-19 pandemic.
Gazali F, Wijayanti N, Hakim M, Supriyati E, Arguni E, Daniwijaya M
Virusdisease. 2023; :1-10.
PMID: 37363361
PMC: 10231289.
DOI: 10.1007/s13337-023-00827-w.
